Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,26 USD | -4,55% | -8,03% | +1,61% |
Omzet 2024 * | 189 mln. 177 mln. | Omzet 2025 * | 164 mln. 154 mln. | Marktkapitalisatie | 264 mln. 247 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -63 mln. -59,1 mln. | Nettowinst (verlies) 2025 * | -70 mln. -65,66 mln. | EV/omzet 2024 * | 1,4 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,6 x |
K/w-verhouding 2024 * |
-4,3
x | K/w-verhouding 2025 * |
-3,98
x | Werknemers | 167 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,33% |
Recentste transcriptie over Akebia Therapeutics, Inc.
1 dag | -4,55% | ||
1 week | -8,03% | ||
1 maand | -31,15% | ||
3 maanden | -25,00% | ||
6 maanden | +43,18% | ||
Lopend jaar | +1,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 01-07-13 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 01-04-22 |
Michel Dahan
COO | Chief Operating Officer | 45 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 12-12-18 |
Adrian Adams
CHM | Chairman | 73 | 12-12-18 |
Director/Board Member | 65 | 16-02-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 1,26 | -4,55% | 4 650 776 |
29-04-24 | 1,32 | -1,49% | 1 974 332 |
26-04-24 | 1,34 | +0,75% | 2 475 964 |
25-04-24 | 1,33 | -2,92% | 2 561 124 |
24-04-24 | 1,37 | -.--% | 1 535 781 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,61% | 276 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |